The co-up-regulation of CPT1A, SCD and FASN indicated that paclitaxel resistance occurrence is a complicated event which involves multiple metabolic processes, including promoted lipid de novo biosynthesis that meets the need of energy supply and materials required for cancer metastases and invasion. The gene discussed is FASN; the disease is cancer.